CD300f/LMIR3/CD300LF Antibody [FITC]

• Reactivity: Mu
• Applications: WB, Flow, CyTOF-ready
• Clonality: Polyclonal
• Host: Goat
• Conjugate: FITC

CD300f/LMIR3/CD300LF Antibody [FITC] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse CD300f/LMIR3
  Cys16-Gly188
  Accession # Q6SJQ7
• Specificity: Detects mouse CD300f/LMIR3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human (rh) LMIR1, rhLMIR2, rhLMIR3, recombinant mouse LMIR5, and rhLMIR6 is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: CD300LF
• Purity: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • CyTOF-ready
  • Flow Cytometry
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Purity: Antigen Affinity-purified

Alternate Names for CD300f/LMIR3/CD300LF Antibody [FITC]

• CMRF35-like molecule 1
• CD300 molecule-like family member f
• CD300f
• CD300LF
• CLIM1
• CLM1
• CLM-1
• DIgR2
• IGSF13
• IREM1
• IREM-1
• LMIR3
• NKIR
• Pigr3

Background

CD300LF is an inhibitory receptor of the Ig superfamily expressed on myeloid cells. It mediates negative regulatorysignals by recruiting SHP1 (PTPN6; MIM 176883) or SHIP (INPP5D; MIM 601582) (Sui et al., 2004 (PubMed 15184070);Alvarez-Errico et al., 2004 (PubMed 15549731)).(supplied by OMIM)

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: CD300LF